(Q39672016)

13 September 2017

title

Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis (English)

1 reference

13 September 2017

Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis (English)

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

16 June 2024

5

Yongsheng Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682645

16 June 2024

author name string

Ying Chen

1

1 reference

13 September 2017

Hua Hao

2

1 reference

13 September 2017

Songqing He

3

1 reference

13 September 2017

Lei Cai

4

1 reference

13 September 2017

Shunze Hu

6

1 reference

13 September 2017

Duyun Ye

7

1 reference

13 September 2017

John Hoidal

8

1 reference

13 September 2017

Ping Wu

9

1 reference

13 September 2017

Xiaoping Chen

10

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20682645

16 June 2024

publication date

3 August 2010

1 reference

full work available at URL

13 September 2017

https://mct.aacrjournals.org/content/molcanther/9/8/2164.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682645

http://intl-mct.aacrjournals.org/cgi/content/abstract/9/8/2164

16 June 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682645

https://aacrjournals.org/mct/article-pdf/9/8/2164/1888588/2164.pdf

16 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Molecular Cancer Therapeutics

16 June 2024

published in

1 reference

13 September 2017

volume

9

1 reference

13 September 2017

issue

8

1 reference

13 September 2017

page(s)

2164-2174

1 reference

VEGF and the quest for tumour angiogenesis factors

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Angiogenesis as a target in neuroblastoma.

16 June 2024

2

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Inflammation and cancer: back to Virchow?

16 June 2024

3

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

16 June 2024

4

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways

16 June 2024

5

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma

16 June 2024

6

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis.

16 June 2024

7

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease

16 June 2024

8

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Effects of lipoxin A(4) on lipopolysaccharide induced proliferation and reactive oxygen species production in RAW264.7 macrophages through modulation of G-CSF secretion

16 June 2024

9

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Posttreatment with aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1

16 June 2024

10

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Formyl-peptide receptor like 1: a potent mediator of the Ca2+ release-activated Ca2+ current ICRAC.

16 June 2024

11

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4).

16 June 2024

12

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor

16 June 2024

13

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis

16 June 2024

14

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Impact of lipoxin-mediated regulation on immune response to infectious disease

16 June 2024

15

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Cutting edge: systemic inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosis

16 June 2024

16

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Inhibition of Lewis lung carcinoma growth by Toxoplasma gondii through induction of Th1 immune responses and inhibition of angiogenesis.

16 June 2024

17

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins

16 June 2024

18

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships

16 June 2024

19

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Protective effects of BML-111, a lipoxin A(4) receptor agonist, on carbon tetrachloride-induced liver injury in mice

16 June 2024

20

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

In vitro endothelial cell susceptibility to xenobiotics: comparison of three cell types

16 June 2024

21

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Amifostine increases cure rate of cisplatin on ascites hepatoma 22 via selectively protecting renal thioredoxin reductase

16 June 2024

22

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy.

16 June 2024

23

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?

16 June 2024

24

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis

16 June 2024

25

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease

16 June 2024

26

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

16 June 2024

27

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells.

16 June 2024

28

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Dysregulation of apoptosis in hepatocellular carcinoma cells

16 June 2024

29

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

16 June 2024

30

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells

16 June 2024

31

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature

16 June 2024

32

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Liver: the formation and actions of aspirin-triggered lipoxins

16 June 2024

33

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.

16 June 2024

34

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

16 June 2024

35

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

The role of hypoxia-inducible factors in tumorigenesis.

16 June 2024

36

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Angiogenesis and the tumour hypoxia response in prostate cancer: a review

16 June 2024

37

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Neuronal and glial alterations due to focal cortical hypoxia induced by direct cobalt chloride (CoCl2) brain injection

16 June 2024

38

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction.

16 June 2024

39

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells

16 June 2024

41

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly

16 June 2024

42

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators

16 June 2024

43

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor

16 June 2024

44

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Role of macrophages in tumour progression.

16 June 2024

45

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Targeting tumor-associated macrophages as a novel strategy against breast cancer

16 June 2024

46

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Autocrine VEGF signaling is required for vascular homeostasis

16 June 2024

47

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.

16 June 2024

48

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

Clinical translation of angiogenesis inhibitors

16 June 2024

49

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy

16 June 2024

50

1 reference

https://api.crossref.org/works/10.1158/1535-7163.MCT-10-0173

16 June 2024

Identifiers

1 reference

13 September 2017

1 reference